v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Net of deferred loan fees $ 2,225 $ 2,230
Valuation allowance 15,702 15,862
Impairment loss on Real estate owned $ 798 $ 1,110
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 200,000,000 200,000,000
Common stock, shares issued (in shares) 47,955,647 47,684,955
Common stock, shares outstanding (in shares) 47,955,647 47,684,955
Series A Preferred Stock    
Preferred stock, par value (in dollars per share) $ 0.001  
Preferred stock, shares authorized (in shares) 3,332,000 3,332,000
Preferred stock, shares issued (in shares) 2,312,758 2,312,758
Preferred stock, shares outstanding (in shares) 2,312,758 2,312,758
Unsecured Debt    
Deferred financing costs $ 1,562 $ 1,905
Senior Notes    
Deferred financing costs 3,298 3,427
Interest and fees receivable    
Valuation allowance 922 2,598
Due from borrower    
Valuation allowance $ 1,791 $ 1,084